Eldar Mordechay Cegla - 18 Mar 2026 Form 3 Insider Report for Innoviz Technologies Ltd. (INVZ)

Role
Chief Financial Officer
Signature
/s/ Dafna Raz - Attorney-in-Fact
Issuer symbol
INVZ
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 18:31:19 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cegla Eldar Mordechay Chief Financial Officer C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL /s/ Dafna Raz - Attorney-in-Fact 18 Mar 2026 0001964080

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INVZ Ordinary Shares 464,053 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 27,084 $0.0569 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 25,286 $1.14 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 52,656 $9.92 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 186,667 $11.50 Direct F3
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 31,280 $5.23 Direct F4
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 39,184 $4.03 Direct F5
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 48,608 $0.7500 Direct F6
holding INVZ Share Option 18 Mar 2026 Ordinary Shares 58,592 $1.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 189,854 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 5,214 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 16,656 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 15,480 RSUs granted February 27, 2024, with 3,488 vesting quarterly through 2027 and 11,992 vesting quarterly through 2028; (d) 28,360 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 16,464 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 54,688 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder RSUs vesting quarterly through 2029; and (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
F2 No exercise price is applicable.
F3 Immediately exercisable.
F4 Share options granted on August 9, 2022. Includes 27,370 vested options, and 3,910 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F5 Share options granted on August 1, 2023. Includes 24,490 vested options, and 14,694 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F6 Share options granted on August 20, 2024. Includes 18,228 vested options, and 30,380 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
F7 Share options granted on August 5, 2025. Includes no vested options, and 58,592 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.

Remarks:

[Exhibit 24 - Power of Attorney.]